These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 3671186)

  • 1. Interactions of ketamine, naloxone and morphine in the rat.
    Fidecka S
    Pol J Pharmacol Pharm; 1987; 39(1):33-40. PubMed ID: 3671186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid mechanisms of some behavioral effects of ketamine.
    Fidecka S
    Pol J Pharmacol Pharm; 1987; 39(4):353-60. PubMed ID: 3449808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine- and morphine-induced analgesia and catalepsy. I. Tolerance, cross-tolerance, potentiation, residual morphine levels and naloxone action in the rat.
    Winters WD; Hance AJ; Cadd GG; Quam DD; Benthuysen JL
    J Pharmacol Exp Ther; 1988 Jan; 244(1):51-7. PubMed ID: 3336011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between ketamine and ethanol in rats and mice.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1989; 41(1):23-32. PubMed ID: 2587434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-tolerance and cross-sensitization between morphine analgesia and naloxone-sensitive and cimetidine-sensitive stress-induced analgesia.
    Weinstein IJ; Hough LB; Gogas KR
    J Pharmacol Exp Ther; 1988 Jan; 244(1):253-8. PubMed ID: 3336002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
    Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
    Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.
    Kreeger JS; Larson AA
    J Pharmacol Exp Ther; 1996 Nov; 279(2):662-7. PubMed ID: 8930169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine.
    Yano I; Takemori AE
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):721-34. PubMed ID: 16322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The enkephalinase mechanisms of the resistance and tolerance to the analgesic effect of morphine in rats. Differences in the effects of naloxone in morphine-sensitive, morphine-resistant and morphine-tolerant rats].
    Kaliuzhnyĭ LV; Kozlov AIu; Litvinova SV
    Biull Eksp Biol Med; 1993 Jul; 116(7):6-9. PubMed ID: 8400186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of morphine tolerance and withdrawal on intestinal salt and water transport in the rat in vivo and in vitro.
    Warhurst G; Smith GS; Higgs N; Tonge A; Turnberg LA
    Gastroenterology; 1984 Nov; 87(5):1035-41. PubMed ID: 6541171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aquaporin 4 deficiency modulates morphine pharmacological actions.
    Wu N; Lu XQ; Yan HT; Su RB; Wang JF; Liu Y; Hu G; Li J
    Neurosci Lett; 2008 Dec; 448(2):221-5. PubMed ID: 18973795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT; Little PJ; Kuhn CM
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia.
    Kalange AS; Kokare DM; Singru PS; Upadhya MA; Chopde CT; Subhedar NK
    Brain Res; 2007 Nov; 1181():10-20. PubMed ID: 17915196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of morphine and naloxone upon the reactions of rats to a heat stressor.
    Westbrook RF; Greeley JD; Nabke CP; Swinbourne AL; Harvey A
    Q J Exp Psychol B; 1991 Aug; 43(3):323-46. PubMed ID: 1658853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
    Dunbar SA; Karamian I; Zhang J
    Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resting and evoked spinal substance P release during chronic intrathecal morphine infusion: parallels with tolerance and dependence.
    Gu G; Kondo I; Hua XY; Yaksh TL
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1362-9. PubMed ID: 15908510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.